Spine. 34(17):1834-1838, August 1, 2009.

Zonal Responsiveness of the Human Intervertebral Disc to Bone Morphogenetic Protein-2.

Kim, Hyang BSc *+; Lee, Jeong-Uk MA *; Moon, Seong-Hwan MD ++; Kim, Hyung-Chan MD ++; Kwon, Un-Hae BSc *; Seol, Nam-Hun MD *; Kim, Ho-Joong MD ++; Park, Jin-Oh MD ++; Chun, Heoung-Jae PhD [S]; Kwon, Il-Keun PhD [P]; Lee, Hwan-Mo MD ++
Institution From the *Medical Science Graduated School, Yonsei University College of Medicine, Seoul, Korea; +Korea Bone Bank Corporation, Institute of Biomaterial and Medical Engineering, Seoul, Korea; ++Department of Orthopaedic Surgery, College of Medicine, Seoul, Korea; [S]Department of Mechanical Engineering, Yonsei University, Seoul, Korea; and [P]Kyung-Hee University, Seoul, Korea.

Study Design. In vitro experiment using bone morphogenetic protein-2 (BMP-2) and cells from the nucleus pulposus (NP), transitional zone (TZ), and anulus fibrosus (AF) of the human intervertebral disc (IVD).

Objective. To demonstrate the differential effect of BMP-2 on DNA synthesis, proteoglycan synthesis, and osteocalcin mRNA expression in human IVD cells from the NP, TZ, and AF, respectively.

Summary of Background Data. BMP-2 has been proven to be effective in stimulating proteoglycan synthesis in articular chondrocytes and IVD cells from the NP. Nevertheless, the effect of BMP-2 on cells from different regions of the IVD has not yet been thoroughly elucidated.

Methods. Human IVDs were harvested from surgical disc procedures and tissue from the NP, TZ, and AF was obtained. Disc tissue was enzymatically digested, and IVD cells were cultured three-dimensionally in alginate beads. Then IVD cell cultures from the NP, TZ, and AF were exposed to BMP-2. DNA synthesis and newly synthesized proteoglycan were measured. Reverse transcription-polymerase chain reaction for mRNA expression of bone sialoprotein, DLX5, osteocalcin, and collagen type I, was performed.

Results. Cells from the AF responded to BMP-2 with mitogenesis. There was no significant increase in DNA synthesis in cultures from the NP and TZ treated with BMP-2. Only cells from the NP showed a significant increase in newly synthesized proteoglycan in response to BMP-2. IVD cells from all zones demonstrated no significant expression of bone sialoprotein, DLX5, osteocalcin mRNA after treatment with BMP-2.

Conclusion. BMP-2 clearly exerted a mitogenic effect on AF cells, and stimulated proteoglycan synthesis in NP cells. However, BMP-2 did not have an osteogenic effect in any IVD region. Taken together, these results confirm that BMP-2 can be used as an anabolic agent for mitogenesis in AF cells and NP cell matrix regeneration without the possibility of osteogenesis.

(C) 2009 Lippincott Williams & Wilkins, Inc.